Improved quality of life and cognition after early vagal nerve stimulator implantation in children

Jehuda Soleman*, Maya Stein, Corine Knorr, Alexandre N. Datta, Shlomi Constantini, Itzhak Fried, Raphael Guzman, Uri Kramer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objective: In patients with drug-resistant epilepsy, reduction of seizure duration and frequency at an early age is beneficial. Vagal nerve stimulator (VNS) was shown to reduce seizure frequency and duration in children; however, data in children under the age of 12 years are sparse. The aim of this study was to compare seizure outcome and quality of life after early (≤ 5 years of age) and late (> 5 years of age) implantation of VNS in children. Methods: This study reviewed 45 consecutive children undergoing VNS implantation. Primary outcome measure was the reduction of seizure frequency. Secondary outcome measures were epilepsy outcome assessed by the McHugh and Engel classifications, reduction of antiepileptic drugs (AEDs), psychomotor development, and quality of life measured by the Pediatric Quality of Life (PEDSQL™) questionnaire and caregiver impression (CGI) scale. The mean follow-up time was 72.3 months (± 39.8 months). Results: Out of 45 patients included, in 14 (31.1%), VNS was implanted early and in 31, (68.9%) late. Reduction of seizure frequency, McHugh and Engel classifications, and reduction of AED were comparable in both groups. Quality of life measured by the CGI scale (2.1 ± 1.7 in the early group vs. 3.6 ± 1.6 in the late group; p = 0.004), as well as the difference of total PEDSQL™ Core scores (12.0 ± 24.0 in the early group vs. − 5.2 ± 14.9 in the late group; p = 0.01) and cognitive PEDSQL™ Core (30.6 ± 32.0 in the early group vs. 2.4 ± 24.3 in the late group; p = 0.03) between preoperative and follow-up was significantly higher in the early implantation group. Conclusion: Early VNS implantation in children leads to a significantly better quality of life and cognitive outcome compared with late implantation while reduction of seizure frequency and epilepsy outcome seems comparable. Therefore, in children with drug-resistant epilepsy, VNS implantation should be considered as early as possible.

Original languageEnglish
Pages (from-to)139-145
Number of pages7
JournalEpilepsy and Behavior
StatePublished - Nov 2018


FundersFunder number
Bohumir-Lukas Foundation
Surgical Research Foundation of the University of Basel


    • Drug-resistant epilepsy
    • Pediatric neurosurgery
    • Psychomotor development
    • Quality of life
    • Vagal nerve stimulator


    Dive into the research topics of 'Improved quality of life and cognition after early vagal nerve stimulator implantation in children'. Together they form a unique fingerprint.

    Cite this